MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Study On Patient- And Caregiver-Reported Symptoms And Outcomes With Levodopa-Carbidopa Intestinal Gel For The Treatment Of Advanced Parkinson’s Disease. ADEQUA Study

    F. Valldeoriola, M.J. Catalán, F. Escamilla-Sevilla, E. Freire, J. Olivares, E. Cubo, D. Santos, J.C. Parra, G. Arroyo, J.M. Arbelo (Barcelona, Spain)

    Objective: The primary objective of the present study was to assess the effect of levodopa-carbidopa intestinal gel (LCIG) on the QoL of patients with advanced…
  • 2018 International Congress

    A Computer-Aided Prescription Model for Parkinson’s Disease could predict the suitable drugs for Parkinson’s disease (PD) patients

    Y. Pan, L. Zhang (Nanjing, China)

    Objective: Using machine learning techniques to automatically recommend suitable drugs for Parkinson’s Disease (PD) patients, thereby providing computer-aided prescriptions. Background: PD is the second most…
  • 2018 International Congress

    Effect of Ba Duan Jin Exercise on Non-Motor Symptoms, Motor Symptoms, Gait and Balance in Patients with Mild to Moderate Parkinson’s Disease

    Z. Cai, S. Dong (Lianyungang City, China)

    Objective: There are many traditional exercises in China such as Taijiquan, Wuqianxi and Ba Duanjin. Studies have shown that Taijiquan can help to improve the…
  • 2018 International Congress

    Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson’s disease: Review of the strategies and perspectives

    C. Cransac, J. Dupouy, P. Loubiere, B. Ackett, P. Cintas, C. Brefel Courbon, O. Rascol, F. ory Magne (Toulouse, France)

    Objective: (1) To make an inventory of the current strategies used to treat or prevent the occurrence of chronic polyneuropathy (CPN) in patients with Parkinson’s…
  • 2018 International Congress

    Evaluation clinical-biochemical features of Parkinson’s disease

    D. Daminov, G. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the cytokine status under different forms and variants of PD course. Background: Parkinson’s disease is clinically heterogeneous; the etiology…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley